Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-03-29
2011-03-29
Wen, Sharon (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C530S388100, C530S388150, C530S387300
Reexamination Certificate
active
07915391
ABSTRACT:
This invention relates to compositions and methods for treating c-Kit associated disorders such as fibrosis, and more particularly, to compositions containing humanized c-Kit antibodies.
REFERENCES:
patent: 5489516 (1996-02-01), Broudy et al.
patent: 5545533 (1996-08-01), Bartke
patent: 5624821 (1997-04-01), Winter
patent: 5808002 (1998-09-01), Buhring
patent: 5919911 (1999-07-01), Broudy et al.
patent: 7144731 (2006-12-01), Zsebo
patent: 2007/0225293 (2007-09-01), Moussy et al.
patent: WO 01/87981 (2001-11-01), None
Rudikoff et al. PNAS 1982 79:1979.
Padlan et al. PNAS 1989, 86:5938-5942.
Bendig Methods: A Companion to Methods in Enzymology 1995; 8:83-93.
The Merck Manuals Online Medical Library, [online]. Whitehouse Station, NJ: Merck Research Laboratories, 2006-2007. [retrieved on Jan. 19, 2009]. Retrieved from the Internet: < URL: http://www.merck.com/mmpe/print/sec19/ch278/ch278a.html>. Cystic Fibrosis, pp. 1-9.
Methods in Molecular Biology, vol. 248: Antibody Engineering: Methods and Protocols, edited by B.K.C. Lo, Humana Press, Totowa, New Jersey, Dec. 5, 2003. pp. 135-159.
Chaudhary, et al., “Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model,” American Journal of Respiratory and Critical Care Medicine Vo 173. pp. 769-776, (2006).
Lukacs, et al., “The role of stem cell factor (c-kit ligand) and inflammatory cytokines in pulmonary mast cell activation,” Blood, 1996 87: 2262-2268.
Li, et al., “Mast cell, a promising therapeutic target in tubulointerstitial fibrosis,” Medical Hypotheses , vol. 69 , Issue 1 , pp. 99-103, 2007.
Masuda, et al., “Mast cells play a partial role in allergen-induced subepithelial fibrosis in a murine model of allergic asthma,” Clinical and experimental allergy, 2003, vol. 33, No. 5, pp. 705-713.
Database Geneseq “Human antiFc epsilon RI alpha chain antibody #1,” Database accession No. AAW73873, 1999.
Database Geneseq “BHA10 VL#2 protein plus heavy constant domain of human IgG1 SeqID 62,” Database accession No. ADJ11354, 2004.
Database Geneseq “Mouse sclerostin-specific antibody protein sequence,” Database accession No. AEM19172, 2007.
Raspollini, et al., c-KIT expression and correlation with chemotherapy resistance in ovarian carcinoma: an immunocytochemical study, Annals of Oncology: Official Journal of the European Society for Medical Oncology, vol. 15, No. 4, Apr. 2004, pp. 594-597.
Written Opinion, PCT Searching Authority, issued Oct. 24, 2008, 7 pgs., 2005.
Hines, “co-expression of c-kit and stem cell factor in breast cancer results in enhanced sensitivity to members of the EGF family of growth factors,” Breast Cancer Research and Treatment, pp. 1-10, vol. 58, No. 1, 1999.
Ahman, et al., “Epitope mapping and functional studies with three monoclonal antibodies to the c-kit receptor tyrosine kinase, YB5.B8, 17F11, and SR-1,” Journal of Cellular Physiology, vol. 158, No. 3, Mar. 1994, pp. 545-554.
Ng Gordon
Shen Wenyan
Amgen Inc.
Sholtz Charles K.
Wen Sharon
LandOfFree
Humanized c-Kit antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Humanized c-Kit antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Humanized c-Kit antibody will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2723908